PL2581387T3 - Przeciwciało monoklonalne anty-Tat HIV-1 - Google Patents

Przeciwciało monoklonalne anty-Tat HIV-1

Info

Publication number
PL2581387T3
PL2581387T3 PL11306314T PL11306314T PL2581387T3 PL 2581387 T3 PL2581387 T3 PL 2581387T3 PL 11306314 T PL11306314 T PL 11306314T PL 11306314 T PL11306314 T PL 11306314T PL 2581387 T3 PL2581387 T3 PL 2581387T3
Authority
PL
Poland
Prior art keywords
hiv
monoclonal antibody
tat monoclonal
tat
antibody
Prior art date
Application number
PL11306314T
Other languages
English (en)
Inventor
Erwann Loret
Gilbert Baillat
Sonia Mediouni
Jennifer Daniele Watkins
Michel Pierres
Original Assignee
Univ Aix Marseille
Inst Nat Sante Rech Med
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Aix Marseille, Inst Nat Sante Rech Med, Centre Nat Rech Scient filed Critical Univ Aix Marseille
Publication of PL2581387T3 publication Critical patent/PL2581387T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1072—Regulatory proteins, e.g. tat, rev, vpt
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • AIDS & HIV (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL11306314T 2011-10-11 2011-10-11 Przeciwciało monoklonalne anty-Tat HIV-1 PL2581387T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11306314.3A EP2581387B1 (en) 2011-10-11 2011-10-11 An anti-HIV-1 Tat monoclonal antibody

Publications (1)

Publication Number Publication Date
PL2581387T3 true PL2581387T3 (pl) 2016-04-29

Family

ID=44862864

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11306314T PL2581387T3 (pl) 2011-10-11 2011-10-11 Przeciwciało monoklonalne anty-Tat HIV-1

Country Status (6)

Country Link
EP (1) EP2581387B1 (pl)
DK (1) DK2581387T3 (pl)
ES (1) ES2553597T3 (pl)
HU (1) HUE026344T2 (pl)
PL (1) PL2581387T3 (pl)
PT (1) PT2581387E (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3077417A1 (en) 2013-12-08 2016-10-12 Peptcell Limited Hiv antigens and antibodies and compositions, methods and uses thereof
WO2021159024A1 (en) * 2020-02-05 2021-08-12 Larimar Therapeutics, Inc. Tat peptide binding proteins and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4550019A (en) 1978-03-22 1985-10-29 South Africa Inventions Development Corporation Manufacture and use of fowl egg antibodies
US5750172A (en) 1987-06-23 1998-05-12 Pharming B.V. Transgenic non human mammal milk
US5633076A (en) 1989-12-01 1997-05-27 Pharming Bv Method of producing a transgenic bovine or transgenic bovine embryo
US5660827A (en) 1992-03-05 1997-08-26 Board Of Regents, The University Of Texas System Antibodies that bind to endoglin
WO1994019935A1 (en) 1993-03-09 1994-09-15 Genzyme Corporation Isolation of components of interest from milk
US5827690A (en) 1993-12-20 1998-10-27 Genzyme Transgenics Corporatiion Transgenic production of antibodies in milk
CN101213212A (zh) * 2005-02-15 2008-07-02 西蒙有限公司 削弱hiv-1增殖的方法和组合物

Also Published As

Publication number Publication date
EP2581387A1 (en) 2013-04-17
ES2553597T3 (es) 2015-12-10
DK2581387T3 (en) 2015-12-07
EP2581387B1 (en) 2015-09-16
PT2581387E (pt) 2015-12-30
HUE026344T2 (en) 2016-05-30

Similar Documents

Publication Publication Date Title
HUS2300021I1 (hu) Anti-IL-36R antitestek
HRP20180640T1 (hr) Anti-b7-h3 antitijelo
HK1257554A1 (zh) 高濃度單克隆抗體配製劑
IL259826A (en) Anti-alphabetatisiar antibody
ZA201400768B (en) Interleukin-31 monoclonal antibody
HK1210620A1 (en) Multi-specific monoclonal antibodies
GB201103955D0 (en) Antibodies
GB201112056D0 (en) Antibodies
TWI563004B (en) Anti-hxcr1 antibody
EP2707392A4 (en) MONOCLONAL ANTIBODY FOR ACETYLAMANTADINE
PL2581387T3 (pl) Przeciwciało monoklonalne anty-Tat HIV-1
EP2769988A4 (en) ANTI-GAP43 ANTIBODY
EP2714074A4 (en) ANTIBODIES AGAINST EMR1